Completed Projects

HOME > R&D Pipeline > Current status > Completed Projects

KDDF-201110-21 Development of Aβ aggregation inhibitor for Alzheimer’s Disease, DWP09031(CNS Diseases, Chemical) [01.04.2013]

PRINT

Development and Market Objectives

Unmet Medical Need & Target Patients

Status

Intellectual Property

Competitive Advantages

Indication

Alzheimer’s disease (central nervous system)

Research Period

Mar.12 , 2012 ~ Dec. 31 , 2012

Company

Daewoong pharmaceutical Co, Ltd.

Developmental Stage

 Phase 1 clinical trial

Additional Information

Contact Information

Contact
Address Company Name: Daewoong pharmaceutical Co, Ltd.
WebSite Homepage: http://www.daewoong.com/ Contact Person:
E-mail: Contact:

Related Projects

Related Project
list
Update to 2013 © KOREA DRUG DEVELOPMENT FUND. ALL RIGHTS RESERVED. QR Code